Islamabad: Pakistan is now all set to manufacture and export Coronavirus treatment medicine named “Remdesivir” with the partnership of the US pharmaceutical company ‘Gilead’.
On Friday, PM’s special assistant on health Dr. Zafar Mirza announced that Pakistan is amongst the three countries that are ready to manufacture and export the medicine.
He further added, “Pakistan’s local manufacturer Ferozsons Laboratories Ltd will not only manufacture but also export the medicines in 127 countries of the world.”
“Remdesivir is an injectable medicine. The production in Pakistan will start within six-eight weeks. Moreover, the registration will be done within five weeks which allows the company to starts its production right after.”
The CEO of Ferozsons, Osman Khalid Waheed announced that
“Gilead and our company we are dedicated to developing medicine at the lowest possible cost and making it accessible in the developing world.”
Remdesivir is an antiviral medicine that shows such promising results in the treatment of COVID-19 patients. Sources have affirmed that this medicine reduces the 30% effect of Coronavirus.
This is to say that, Regulators in the USA allow this medicine to use in an emergency to cure Coronavirus.
Besides Pakistan, Gilead has signed the agreement with four drugs manufacturing firms in India.
Gilead said that under “unlicensed” agreements with South Asian partners, all companies would have the right to receive a technology transfer of the company’s process for Remdesivir to quicken the manufacturing of medicine.
Relaxing Lockdown in Pakistan
Pakistan has confirmed 39,473 cases from March from which 847 deaths occurred till now. Despite this breakneck situation the Government of Pakistan began lifting these lockdowns from the last few weeks.
Consequently, PM has defended this situation saying:
“There are 150 million people in Pakistan who are daily wagers, laborers, and low-income individuals. If we do not ease the lockdown they might die of starvation.”
Share your thoughts in the Comment Section below!